Save time and get answers to complex questions with AI chat
Drugpatentwatch market analysis industry today?Testosterone enanthate expiration?Mebendazole for kids price?Sun pharma bortezomib?Zemdri nce gain exclusivity 2028 patent 2031?
See the DrugPatentWatch profile for trintellix
Trintellix (vortioxetine) is classified as an antidepressant. It specifically acts as a serotonin modulator and stimulator (often described as a “multimodal” serotonergic agent), meaning it affects multiple serotonin receptors rather than only blocking serotonin reuptake.[1]
Vortioxetine works by influencing serotonin signaling through several mechanisms, including serotonin transporter (SERT) inhibition and activity at different serotonin receptors. This receptor-by-receptor pattern is why it’s commonly grouped with “serotonin modulators” rather than as a simple selective serotonin reuptake inhibitor (SSRI).[1]
Unlike many traditional SSRIs (which primarily focus on blocking SERT), Trintellix’s label pharmacology centers on both SERT inhibition and serotonin receptor modulation, which is why it’s often described as having a broader serotonergic profile than an SSRI.[1] Sources: 1. https://www.drugs.com/trintellix.html
Other Questions About Trintellix :